Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
---|
02/27/2007 | US7183045 Removal of adenine during a pathogen reduction process in whole blood or red blood cell by dilution |
02/27/2007 | US7182960 Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone |
02/22/2007 | WO2006089007A3 Cyclodextrin-based polymers containing photocleavable linkers for drug delivery |
02/22/2007 | US20070041995 Oral compositions for HIV-infected subjects |
02/22/2007 | CA2619695A1 Therapy with cd4 binding peptides and radiation |
02/21/2007 | EP1753468A2 Carboranylporphyrins and uses thereof |
02/21/2007 | EP1753457A2 Cationic bacteriochlorophyll derivatives and uses thereof |
02/20/2007 | US7181271 Synergism of photodynamic and electropermeation effect on cell vitality as a novel cytotoxic agent |
02/20/2007 | CA2218872C Preparation and use of sulfated oligosaccharides |
02/15/2007 | WO2007016762A1 Perylenequinone derivatives and uses thereof |
02/15/2007 | US20070037825 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
02/15/2007 | US20070036820 Yeast compositions useful as anti-aging dietary supplements |
02/15/2007 | CA2820233A1 Perylenequinone derivatives and uses thereof |
02/15/2007 | CA2615510A1 Perylenequinone derivatives and uses thereof |
02/14/2007 | EP1750664A1 Intravitreal implants in conjunction with photodynamic therapy to improve vision |
02/14/2007 | EP1379260B1 Methods for treating the inflammatory component of a brain disorder |
02/14/2007 | EP1171144B1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa |
02/14/2007 | EP0707476B1 Compounds for the photodecontamination of pathogens in blood |
02/13/2007 | US7176327 Water soluble, biologically inert Pt(IV) compounds which can be converted to cytotoxic Pt(II) species by photoactivation; reduced side effect anticancer drugs |
02/13/2007 | CA2275191C Phosphorescent dendritic macromolecular compounds for imaging tissue oxygen |
02/08/2007 | WO2006048633A3 Combination comprising zd6474 and an antiandrogen |
02/08/2007 | CA2617869A1 Nanoparticles comprising antibacterial ligands |
02/07/2007 | CN1909927A Method of suppressing cancer |
02/07/2007 | CN1909920A Method for the delivery of sustained release agents |
02/07/2007 | CN1298328C Combination therapy comprising ZD6474 and a taxane |
02/06/2007 | US7173011 Radiation therapy methods |
02/06/2007 | US7172889 Orally administered; activated and conditioned yeast cells cultured in electromagnetic fields |
02/06/2007 | US7172888 Orally administered; activated and conditioned yeast cells; culturing yeast cells of Saccharomyces cerevisiae Hansen strain electromagnetic fields |
02/06/2007 | CA2287262C Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
02/02/2007 | WO2007019845A2 Method for encapsulating therapeutic substances in cells |
02/02/2007 | CA2619278A1 Method for encapsulating therapeutic substances in cells |
02/01/2007 | WO2007012209A1 Production of means for improving the state of systems and materials |
02/01/2007 | WO2006064205A3 Process for the preparation of a boron-substituted porphyrin |
02/01/2007 | US20070027129 Taxane, magnetic moiety and covalent binder for production of magnetic antimitotic agent with higher toxicity to cancer cells than normal cells |
02/01/2007 | US20070026001 APO-2 ligand-anti-her-2 antibody synergism |
02/01/2007 | DE10301917B4 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren Use of substances of the porphyrin synthesis in the phototherapy of skin or joint disease of humans or mammals |
01/31/2007 | EP1747026A1 Biomolecular contrast agents for therapy control in radiation therapy with proton or ion beams |
01/31/2007 | EP1747018A2 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy |
01/30/2007 | US7169753 Such as magnesium-containing tetrahydroporphyrin for use in photodynamic therapy, tumor diagnosis, bactericides, and viricides; transesterification |
01/30/2007 | US7169558 Using non-radioactive markers to identify nascent proteins translated within cellular or cell-free translation systems; bioremediation and pollution contol of biohazards |
01/25/2007 | WO2007011680A2 Ligands to radiation-induced molecules |
01/25/2007 | WO2006110176A3 Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor |
01/25/2007 | WO2004063342A3 Cellular delivery and activation polypeptide-nucleic acid complexes |
01/25/2007 | US20070020643 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered |
01/25/2007 | US20070020272 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use thereof |
01/25/2007 | US20070020241 Use of photosensitisation |
01/24/2007 | EP1746610A2 Magnetic nanoparticles of noble metals |
01/24/2007 | EP1744789A1 Activatable particles, preparations and uses |
01/24/2007 | EP1744783A1 Compositions comprising cells and magnetic materials for targeted delivery |
01/24/2007 | EP1744741A2 Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer |
01/24/2007 | EP1276501B9 Method for treatment of tumors using photodynamic therapy |
01/23/2007 | CA2288045C A new class of benzoporphyrin derivative photoactive compounds |
01/18/2007 | US20070015816 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
01/17/2007 | EP1742611A2 Remote control release of material encapsulated in polyelectrolyte multilayer microcapsules |
01/17/2007 | EP1283047B1 Method for producing a bioactive substance from blood serum |
01/17/2007 | CN1898378A Stem cell targeting using magnetic particles |
01/17/2007 | CN1898249A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
01/17/2007 | CN1897979A Gas-filled microvesicle assembly for contrast imaging |
01/17/2007 | CN1897978A Assembly of gas-filled microvesicle with active component for contrast imaging |
01/17/2007 | CN1895206A Skin nursing-agent electric-field activating method and device |
01/16/2007 | US7163813 Biological compositions and methods for treatment of colorectal cancer |
01/16/2007 | US7163397 Apparatus for applying material for selectively modifying the optical properties of metabolically different cells |
01/16/2007 | CA2294196C Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery |
01/16/2007 | CA2069759C Liposomes as contrast agents for ultrasonic imaging |
01/11/2007 | WO2006119284A3 Conjugated aromatic compounds for diagnosis and therapy |
01/11/2007 | US20070010575 Intracorporeal medicaments for photodynamic treatment of disease |
01/11/2007 | US20070009576 Nutritionally fortified liquid composition with added value delivery systems/elements/additives |
01/10/2007 | EP1740144A2 Phototherapy systems and methods |
01/10/2007 | EP1562642B1 Device and process for treating a liquid medium using ultrasound in preventing the growth of hyperproliferative or infected cells |
01/10/2007 | EP1451300A4 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
01/10/2007 | EP1206288B1 Targeted fiberless radiative effectors |
01/10/2007 | CN1894344A Compounds for dual photodiagnosis and therapy |
01/10/2007 | CN1893976A Radiation therapy and medical imaging using uv emitting nanoparticles |
01/10/2007 | CN1893961A Biologically active blood serum obtained by electroshock |
01/10/2007 | CN1891295A Method for preparing liquid medicine preparation for further promoting intrinsic quality |
01/09/2007 | US7160908 Platinum amine glycine complex derivatives; antiproliferative and antitumor agents; side effect reduction; reversibly active; on and off |
01/09/2007 | US7160873 Texaphyrin coordination compounds and uses thereof |
01/09/2007 | CA2400801C Treatment of congestive heart failure by pretreated autologous blood |
01/09/2007 | CA2162732C Use of modified tall-104 cells to treat cancer and viral diseases |
01/08/2007 | CA2528635A1 Tumor treatment using beta-sheet peptides and radiotherapy |
01/04/2007 | US20070004756 Pharmaceutical compositions |
01/04/2007 | US20070003430 Method of inactivating microorganisms in a fluid using ultraviolet radiation |
01/03/2007 | EP1737492A1 Preparation for the photodynamic control of micro-organisms and use of said preparation |
01/03/2007 | EP1701726A4 Antimicrobial photodynamic therapy compound and method of use |
01/02/2007 | US7157477 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
01/02/2007 | US7157458 Bifunctional energy-reversible acyl-compositions |
12/28/2006 | WO2006138330A2 Tissue treatment methods |
12/28/2006 | WO2006089251A3 SYNERGISTIC EFFECT OF TGF-β BLOCKADE AND IMMUNOGENIC AGENTS ON TUMORS |
12/28/2006 | US20060293323 Therapeutic Combinations of erb B Kinase Inhibitors and Antineoplastic Therapies |
12/28/2006 | US20060292112 Dendrimer-photosensitizer complexes for medical applications |
12/28/2006 | US20060292072 Agents for neutron capture therapy |
12/27/2006 | EP1313695B1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
12/26/2006 | US7153841 Conjugates with carriers; red shifted absorption; antiproliferative and antitumor agents; benign prostatic hyperplasia; diagnosis |
12/26/2006 | US7153649 Applying stresses to blood sampling |
12/21/2006 | WO2006134365A1 Method of providing magnetised particles at a location |
12/21/2006 | WO2006088476A3 Carboranylporphyrins and uses thereof |
12/21/2006 | US20060287220 Water soluble paclitaxel prodrugs |
12/20/2006 | EP1732594A2 Method for the delivery of sustained release agents |
12/14/2006 | US20060282136 Switched photodynamic therapy apparatus and method |
12/14/2006 | US20060282038 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |